Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00GWR
|
||||
| Former ID |
DNC000485
|
||||
| Drug Name |
CT301
|
||||
| Indication | Discovery agent | Investigative | [535621] | ||
| Target and Pathway | |||||
| Target(s) | Integrin alpha-4 | Target Info | Antagonist | [535621] | |
| KEGG Pathway | PI3K-Akt signaling pathway | ||||
| Focal adhesion | |||||
| ECM-receptor interaction | |||||
| Cell adhesion molecules (CAMs) | |||||
| Hematopoietic cell lineage | |||||
| Leukocyte transendothelial migration | |||||
| Intestinal immune network for IgA production | |||||
| Regulation of actin cytoskeleton | |||||
| Leishmaniasis | |||||
| Hypertrophic cardiomyopathy (HCM) | |||||
| Arrhythmogenic right ventricular cardiomyopathy (ARVC) | |||||
| Dilated cardiomyopathy | |||||
| PANTHER Pathway | Integrin signalling pathway | ||||
| Pathway Interaction Database | Beta1 integrin cell surface interactions | ||||
| Integrin family cell surface interactions | |||||
| Arf6 trafficking events | |||||
| CXCR4-mediated signaling events | |||||
| Plexin-D1 Signaling | |||||
| a4b7 Integrin signaling | |||||
| Beta5 beta6 beta7 and beta8 integrin cell surface interactions | |||||
| VEGFR3 signaling in lymphatic endothelium | |||||
| Alpha4 beta1 integrin signaling events | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.